Top

Clinical and Translational Oncology

Published in:

01-02-2016 | Research Article

Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?

Authors: M. Grimm, B. Calgéer, P. Teriete, T. Biegner, A. Munz, S. Reinert

Published in: Clinical and Translational Oncology | Issue 2/2016

Abstract

Purpose

Thiamine-dependent enzymes (TDEs) linking glycolysis with the tricarboxylic acid cycle (TCA) pyruvate dehydrogenase (PDH), of the pentose phosphate pathway transketolases (TKTs), the TCA alpha-ketoglutarate deydrogenase (KGDH)/2-oxoglutarate dehydrogenase (OGDH) complex, and the amino acid catabolism branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex are crucial factors for tumor metabolism. The expression of these enzymes has not been analyzed for carcinogenesis of oral squamous cell carcinoma (OSCC) with special focus on new targeted metabolic therapies as yet.

Methods

TDEs PDH, KGDH (OGDH), and BCKDH were analyzed in normal oral mucosa (n = 14), oral precursor lesions (simple hyperplasia, n = 21; squamous intraepithelial neoplasia, SIN I–III, n = 35), and OSCC specimen (n = 46) by immunohistochemistry and western blot (WB) analysis in OSCC tumor cell lines.

Results

Although the total numbers of PDH and KGDH (OGDH) positive samples decreased in OSCC, both enzymes were significantly overexpressed in the carcinogenesis of OSCC compared with normal tissue. BCKDH has been demonstrated to be significantly overexpressed in the carcinogenesis of OSCC. Specificity of the antibodies was confirmed by WB analysis.

Conclusions

This is the first study showing increased expression of TDEs in OSCC. Metabolic targeting of TDEs (including TKTs) by antagonistic compounds like oxythiamine or oxybenfothiamine may be a useful strategy to sensitize cancer cells to common OSCC cancer therapies.

Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, Teriete P, et al. Association of cancer metabolism-related proteins with oral carcinogenesis—indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? J Transl Med. 2014;12:208. doi:10.1186/1479-5876-12-208.PubMedCentralCrossRefPubMed

Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Investig. 2013;123(9):3678–84. doi:10.1172/JCI69600.PubMedCentralCrossRefPubMed

Alfarouk KO, Shayoub ME, Muddathir AK, Elhassan GO, Bashir AH. Evolution of Tumor Metabolism might reflect carcinogenesis as a reverse evolution process (dismantling of multicellularity). Cancers Basel. 2011;3(3):3002–17. doi:10.3390/cancers3033002.PubMedCentralCrossRefPubMed

Cetindis M, Biegner T, Munz A, Teriete P, Reinert S, Grimm M. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma. Eur Arch Oto Rhino Laryngol Off J Eur Fed Oto Rhino Laryngol Soc. 2015;. doi:10.1007/s00405-015-3543-7.

Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab. 2015;3(1):1. doi:10.1186/s40170-015-0128-2.PubMedCentralCrossRefPubMed

Zheng J. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncol Lett. 2012;4(6):1151–7. doi:10.3892/ol.2012.928.PubMedCentralPubMed

Ramos-Montoya A, Lee WN, Bassilian S, Lim S, Trebukhina RV, Kazhyna MV, et al. Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int J Cancer J Int Du Cancer. 2006;119(12):2733–41. doi:10.1002/ijc.22227.CrossRef

Grimm M, Schmitt S, Teriete P, Biegner T, Stenzl A, Hennenlotter J, et al. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer. 2013;13(1):569. doi:10.1186/1471-2407-13-569.PubMedCentralCrossRefPubMed

Grimm M, Munz A, Teriete P, Nadtotschi T, Reinert S. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral pathol Oral Radiol. 2014;117(6):743–53. doi:10.1016/j.oooo.2014.02.007.CrossRefPubMed

10.

Caneba CA, Bellance N, Yang L, Pabst L, Nagrath D. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration. Am J Physiol Endocrinol Metab. 2012;303(8):E1036–52. doi:10.1152/ajpendo.00151.2012.CrossRefPubMed

11.

Zastre JA, Sweet RL, Hanberry BS, Ye S. Linking vitamin B1 with cancer cell metabolism. Cancer Metab. 2013;1(1):16. doi:10.1186/2049-3002-1-16.PubMedCentralCrossRefPubMed

12.

Xu X, Zur Hausen A, Coy JF, Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer J Int Du Cancer. 2009;124(6):1330–7. doi:10.1002/ijc.24078.CrossRef

13.

Santos CR, Schulze A. Lipid metabolism in cancer. The FEBS journal. 2012;279(15):2610–23. doi:10.1111/j.1742-4658.2012.08644.x.CrossRefPubMed

14.

Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr. 1984;4:409–54. doi:10.1146/annurev.nu.04.070184.002205.CrossRefPubMed

15.

Harris RA, Joshi M, Jeoung NH, Obayashi M. Overview of the molecular and biochemical basis of branched-chain amino acid catabolism. J Nutr. 2005;135(6 Suppl):1527S–30S.PubMed

16.

Platell C, Kong SE, McCauley R, Hall JC. Branched-chain amino acids. J Gastroenterol Hepatol. 2000;15(7):706–17.CrossRefPubMed

17.

Meijer TW, Kaanders JH, Span PN, Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res Off J Am Assoc Cancer Res. 2012;18(20):5585–94. doi:10.1158/1078-0432.CCR-12-0858.CrossRef

18.

Sattler UG, Mueller-Klieser W. The anti-oxidant capacity of tumour glycolysis. Int J Radiat Biol. 2009;85(11):963–71. doi:10.3109/09553000903258889.CrossRefPubMed

19.

Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–91. doi:10.1038/nrd2803.CrossRefPubMed

20.

Tanaka T, Tanaka M, Tanaka T. Oral carcinogenesis and oral cancer chemoprevention: a review. Patholog Res Int. 2011;2011:431246. doi:10.4061/2011/431246.PubMedCentralPubMed

21.

Driemel O, Hertel K, Reichert TE, Kosmehl H. Current classification of precursor lesions of oral squamous cell carcinoma principles of the WHO classification 2005. Mund Kiefer Gesichtschir. 2006;10(2):89–93. doi:10.1007/s10006-006-0675-3.CrossRefPubMed

22.

Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010;10(4):267–77. doi:10.1038/nrc2817.CrossRefPubMed

23.

Sobin LH, Ch W, editors. UICC TNM classification of malignant tumors Berlin. 7th ed. Berlin: Springer Verlag; 2010.

24.

Hamilton SR, Aaltonen LA. Pathology and genetics. Tumours of the digestive system. 3rd ed. Lyon: IARC Press; 2000.

25.

Walker RA. Quantification of immunohistochemistry–issues concerning methods, utility and semiquantitative assessment I. Histopathology. 2006;49(4):406–10. doi:10.1111/j.1365-2559.2006.02514.x.CrossRefPubMed

26.

Grimm M, Munz A, Teriete P, Nadtotschi T, Reinert S. GLUT-1 +/TKTL1 + co-expression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(6):743–53.CrossRefPubMed

27.

Edington KG, Loughran OP, Berry IJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog. 1995;13(4):254–65.CrossRefPubMed

28.

Alexander D, Schafer F, Olbrich M, Friedrich B, Buhring HJ, Hoffmann J, et al. MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2010;26(6):1073–80. doi:10.1159/000323985.CrossRef

29.

Grimm M, Alexander D, Munz A, Hoffmann J, Reinert S. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma. Clin Exp Metastasis. 2013;30(4):529–40. doi:10.1007/s10585-012-9557-2.CrossRefPubMed

30.

Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, et al. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16(3):857–66. doi:10.1158/1078-0432.CCR-09-2604.CrossRef

31.

Liu S, Miriyala S, Keaton MA, Jordan CT, Wiedl C, Clair DK, et al. Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells. PLoS One. 2014;9(1):e85702. doi:10.1371/journal.pone.0085702.PubMedCentralCrossRefPubMed

32.

Mandujano-Tinoco EA, Gallardo-Perez JC, Marin-Hernandez A, Moreno-Sanchez R. Rodriguez-Enriquez S (2013) Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids. Biochim Biophys Acta. 1833;3:541–51. doi:10.1016/j.bbamcr.2012.11.013.

33.

Dang CV. Links between metabolism and cancer. Genes Dev. 2012;26(9):877–90. doi:10.1101/gad.189365.112.PubMedCentralCrossRefPubMed

34.

Wigfield SM, Winter SC, Giatromanolaki A, Taylor J, Koukourakis ML, Harris AL. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer. 2008;98(12):1975–84. doi:10.1038/sj.bjc.6604356.PubMedCentralCrossRefPubMed

35.

McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, Halim N, et al. Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem. 2008;283:22700–8.PubMedCentralCrossRefPubMed

36.

Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, Tumor, et al. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia. 2005;7(1):1–6.PubMedCentralCrossRefPubMed

37.

Stacpoole PW. The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases. Aging Cell. 2012;11(3):371–7. doi:10.1111/j.1474-9726.2012.00805.x.CrossRefPubMed

38.

Stuart SD, Schauble A, Gupta S, Kennedy AD, Keppler BR, Bingham PM, et al. A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process. Cancer Metab. 2014;2(1):4. doi:10.1186/2049-3002-2-4.PubMedCentralCrossRefPubMed

39.

Harris RA, Joshi M, Jeoung NH. Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun. 2004;313(2):391–6.CrossRefPubMed

40.

Wang J, Zhang X, Ma D, Lee WN, Xiao J, Zhao Y, et al. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Exp Hematol Oncol. 2013;2:18. doi:10.1186/2162-3619-2-18.PubMedCentralCrossRefPubMed

41.

Rais B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D, et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich’s tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999;456(1):113–8.CrossRefPubMed

42.

Boros L, Puigjaner J, Cascante M, Lee W-N, Brandes J, Bassilian S, et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997;57:4242–8.PubMed

43.

Hamabe A, Yamamoto H, Konno M, Uemura M, Nishimura J, Hata T, et al. Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1alpha in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis. Cancer Sci. 2014;105(9):1100–8. doi:10.1111/cas.12487.PubMedCentralCrossRefPubMed

44.

DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20. doi:10.1016/j.cmet.2007.10.002.CrossRefPubMed

45.

Hurd TR, DeGennaro M, Lehmann R. Redox regulation of cell migration and adhesion. Trends Cell Biol. 2012;22(2):107–15. doi:10.1016/j.tcb.2011.11.002.PubMedCentralCrossRefPubMed

46.

Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 2005;51(5–6):257–73.PubMed

47.

Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755–68. doi:10.1038/nrc2499.CrossRefPubMed

48.

Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23–8.CrossRefPubMed

49.

Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle. 2007;6(19):2332–8. doi:10.4161/cc.6.19.4914.CrossRefPubMed

50.

Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10(3):175–6. doi:10.1016/j.ccr.2006.08.015.CrossRefPubMed

51.

Frezza C, Gottlieb E. Mitochondria in cancer: not just innocent bystanders. Semin Cancer Biol. 2009;19(1):4–11. doi:10.1016/j.semcancer.2008.11.008.CrossRefPubMed

52.

Simon H, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5:415–8.CrossRefPubMed

53.

Grimm M. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC. Clinical Transl Oncol Off Pub Fed Spanish Oncol Soc National Cancer Inst Mexico. 2012;14(11):870–80. doi:10.1007/s12094-012-0867-2.

54.

Perez-Sayans M, Suarez-Penaranda JM, Pilar GD, Barros-Angueira F, Gandara-Rey JM, Garcia-Garcia A. Hypoxia-inducible factors in OSCC. Cancer Lett. 2011;313(1):1–8. doi:10.1016/j.canlet.2011.08.017.CrossRefPubMed

55.

Heier M, Dornish J. Effect of the fluoropyrimidines 5-fluorouracil and doxifluridine on cellular uptake of thiamin. Anticancer Res. 1989;9:1073–7.PubMed

56.

Aksoy M, Basu T, Brient J, Dickerson J. Thiamin status of patients treated with drug combinations containing 5-fluorouracil. Eur J Cancer. 1980;16:1041–5.CrossRefPubMed

57.

Sweet R, Paul A, Zastre J. Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line. Cancer Biol Ther. 2010;10:1101–11.CrossRefPubMed

58.

Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 2002;277(26):23111–5. doi:10.1074/jbc.M202487200M202487200.CrossRefPubMed

59.

Boros L. Population thiamine status and varying cancer rates between western, Asian and African countries. Anticancer Res. 2000;20:2245–8.PubMed

60.

Lee B, Yanamandra K, Bocchini J. Thiamin deficiency: a possible major cause of some tumors? Oncol Rep. 2005;14:1589–92.PubMed

61.

Kabat G, Miller A, Jain M, Rohan T. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer. 2008;99:816–21.PubMedCentralCrossRefPubMed

Title: Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?
Authors: M. Grimm
B. Calgéer
P. Teriete
T. Biegner
A. Munz
S. Reinert
Publication date: 01-02-2016
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 2/2016
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-015-1352-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2016

VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells

Yes-associated protein (YAP) expression is involved in epithelial–mesenchymal transition in hepatocellular carcinoma

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma

Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients

miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers

Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer